GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (LTS:0RN3) » Definitions » Non Operating Income

Takeda Pharmaceutical Co (LTS:0RN3) Non Operating Income : €-472 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Takeda Pharmaceutical Co Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Takeda Pharmaceutical Co's Non Operating Income for the three months ended in Jun. 2024 was €-4 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was €-472 Mil.


Takeda Pharmaceutical Co Non Operating Income Historical Data

The historical data trend for Takeda Pharmaceutical Co's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Non Operating Income Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,432.55 821.62 -760.19 -328.04 -716.29

Takeda Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.73 12.83 252.36 -733.06 -4.19

Takeda Pharmaceutical Co Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co Non Operating Income Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines